1. 1802 Overall survival (OS) from the phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) signaling inhibitor, in AR+ advanced triple-negative breast cancer (aTNBC). (September 2015) Authors: Cortes, J.; Crown, J.; Awada, A.; Schmid, P.; Gianni, L.; Garcia-Estevez, L.; Martinez-Janez, N.; Chan, S.; Steinberg, J.L.; Blaney, M.; Tudor, I.C.; Uppal, H.; Peterson, A.; Miller, K.; Yardley, D.A.; Hudis, C.A.; Traina, T.A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1879 Impact of adjuvant trastuzumab (adjT) for early-stage (ES) breast cancer (BC) on clinical characteristics, survival and likelihood of durable complete response (DCR) of HER2-positive (HER2+) metastatic breast cancer (MBC): A 15-year single-institution cohort study. (September 2015) Authors: Zacchia, A.; Gullo, G.; Parker, I.; De Giorgi, A.; Fennelly, D.; Zanoni, D.; Walshe, J.; Defrein, A.M.; Quinn, C.; Silva, N.; O' Donovan, N.; Ballot, J.; Mc Dermott, E.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1939 Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant Doxorubicin: 10-Year follow-up. (September 2015) Authors: Murtagh, G.; O'Connell, E.; Lyons, T.; Ballot, J.; Jones, M.; Geraghty, L.; Gullo, G.; Crown, J.; McDonald, K.; Walsh, J.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10. (September 2015) Authors: Gullo, G.; Kennedy, J.; Breathnach, O.; McCaffrey, J.; Keane, M.; Martin, M.; Gupta, R.; Leonard, G.; Calvert, P.; Donnellan, P.; Walshe, J.; Mc Dermott, E.; Cairney, S.; Bose, R.; Scott, K.; Hernando, A.; Parker, I.; Tryfonopoulos, D.; Moulton, B.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 238 Chromosomal instability in cancer and immune-related genes. (September 2015) Authors: Madden, S.F.; Collins, D.M.; Gaynor, N.; Gallagher, W.M.; O'Donovan, N.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 239 Tyrosine kinase inhibitors (TKIs) enhance response to HER2 targeted antibodies. (September 2015) Authors: Ivers, L.; Collins, D.; Canonici, A.; Gullo, G.; O'Donovan, N.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 3315 Pattern of systemic relapse and outcome of patients (pts) with ocular melanoma (OM) after curative local therapy (Rx): Results of an active surveillance strategy. (September 2015) Authors: Coleman, N.; Gullo, G.; Greally, M.; Kelly, C.; Power, B.; Kennedy, S.; Hoti, E.; Horgan, N.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical factors associated with overall survival (OS) for patients with HER2-positive (HER2+) metastatic breast cancer (MBC) treated with HER2-targeting systemic therapy (HER2Tx). (February 2017) Authors: Gullo, G.; Walsh, N.; Zacchia, A.; Hammond, L.; Fennelly, D.; Walshe, J.; O'Mahony, K.; Maltese, M.; Crown, J. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Functional genomic screening identifies USP11 as a novel therapeutic target in breast cancer. (July 2016) Authors: Dwane, L.; O'Connor, A.; Mulrane, L.; Klinger, R.; Dirac, A.; Jirstrom, K.; Crown, J.; Bernards, R.; Gallagher, W.; O'Connor, D. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Modeling the long-term efficacy of neratinib in the extended adjuvant setting for women with HER2+/HR+ early stage breast cancer (ESBC). (March 2019) Authors: Doan, Q.; Lalla, D.; Yao, B.; Danese, M.; Barnett, B.; Crown, J. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗